Accelus Gains FDA Clearance for Toro-L Interbody Fusion

Toro-L was designed to offload the pressure on the innervated posterior psoas muscle without sacrificing footprint.

The company grew more than 55% in 1Q22 on the strength of its narrow procedure focus and expanding direct sales force.

Dave Demski, President and CEO, resigned after nearly 20 years with the company. Daniel T. Scavilla has been named as his replacement, effective immediately.

Emmanuel Bonhomme will step in as Luigi Ferrari leaves to pursue new activities.

Enovis will stand as an entirely new public company solely focused on medical technology.

Companies set their sights on enabling technology, ASCs, personalized procedures and implants, registries and director-to-consumer marketing.

Orthopedic Market Unlikely to Find Reprieve in 2022

Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022.

Member-Only Content

SUBSCRIBE Login

R&D Spend Just One Problem for Lagging Portfolios

Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies.

We spoke to ZimVie CEO Vafa Jamali about the new opportunities and finding the right areas of the spine market to drive innovation.

Member-Only Content

SUBSCRIBE Login

Meet eight companies exhibiting at AAOS for the first time. Discover new devices and materials, as well as a collection of digital surgical tools.

Accelus Gains FDA Clearance for Toro-L Interbody Fusion

Toro-L was designed to offload the pressure on the innervated posterior psoas muscle without sacrificing footprint.

DePuy Synthes Enhances the ATTUNE Knee Portfolio

The ATTUNE Cementless Fixed Bearing Knee with AFFIXIUM 3DP Technology and the ATTUNE Medial Stabilized Knee are designed for more natural knee function.

Carbon22 Gains FDA 510(k) for Apollo Ankle Plates

Apollo Ankle Fracture Plating comprises see-through, ortholucent bone plates and screws used for orthopedic ankle fracture surgery.

5 Market Opportunities for Small Orthopedic Companies

Companies set their sights on enabling technology, ASCs, personalized procedures and implants, registries and director-to-consumer marketing.

Based on their commentary in the fourth quarter of 2021, orthopedic executives expect market disruption to persist through 2022.

Lower than average R&D spending combined with organizational challenges have slowed two of the largest orthopedic companies.

2022 Outlook: Insight for Building Relationships and Strategies

What are the most significant opportunities and challenges for the orthopedic industry in 2022? Regulatory commentators weigh in.

Member-Only Content

SUBSCRIBE Login

What Orthopedic Companies Need to Know about Hospital Supply Chains

The dust is starting to settle about what may be long-term in the orthopedic manufacturer-to-hospital supply chain and what may have been an anomaly.

Exactech’s Retiring Founder and R&D Leader Shares Lessons Learned

A few months ago, Gary Miller, Ph.D., gave a commencement speech to the University of Florida's graduating engineers. It was a fitting honor for a man who has dedicated decades to the field of engineering and was on the verge of a new chapter himself....

Why Orthopedic Companies Struggle with Developing Patient Engagement Software

Implant companies are headed for self-imposed and avoidable failure with their patient engagement software.

Orthopedic Urgent Care Pioneer Offers Novel Views on Outpatient Environment

Dr. Alejandro Badia, Hand and Upper Limb Surgeon, shared perspectives on healthcare, vendor engagement and pursuit of clinical and business leadership and influence.

New Journal Focuses on Orthopedic Experience and Innovation

Surgeon entrepreneurs launch the Journal of Orthopaedic Experience & Innovation that highlights clinical, economic and industry innovations.

Accelus Gains FDA Clearance for Toro-L Interbody Fusion

Treace Benefits from Commercial Investments

Globus Medical Reports CEO Transition

LimaCorporate Appoints Interim CEO

DJO Transitions Brand to Enovis

5 Market Opportunities for Small Orthopedic Companies

Orthopedic Market Unlikely to Find Reprieve in 2022

Member-Only Content

R&D Spend Just One Problem for Lagging Portfolios

ZimVie CEO on Driving Stability and Innovation in Spine

Member-Only Content

First-time AAOS Exhibitors: New Devices and Digital Offerings

Additive

Accelus Gains FDA Clearance for Toro-L Interbody Fusion

DePuy Synthes Enhances the ATTUNE Knee Portfolio

Carbon22 Gains FDA 510(k) for Apollo Ankle Plates

Editor's Picks

5 Market Opportunities for Small Orthopedic Companies

Orthopedic Market Unlikely to Find Reprieve in 2022

R&D Spend Just One Problem for Lagging Portfolios

Industry Voices

2022 Outlook: Insight for Building Relationships and Strategies

Member-Only Content

What Orthopedic Companies Need to Know about Hospital Supply Chains

Exactech’s Retiring Founder and R&D Leader Shares Lessons Learned

Surgeon Voices

Why Orthopedic Companies Struggle with Developing Patient Engagement Software

Orthopedic Urgent Care Pioneer Offers Novel Views on Outpatient Environment

New Journal Focuses on Orthopedic Experience and Innovation